GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kodiak Sciences Inc (FRA:K27) » Definitions » Price-to-Funds-From-Operations

Kodiak Sciences (FRA:K27) Price-to-Funds-From-Operations : (As of May. 11, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Kodiak Sciences Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Kodiak Sciences (FRA:K27) Business Description

Industry
Traded in Other Exchanges
Address
1200 Page Mill Road, Palo Alto, CA, USA, 94304
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.